Similarly, of n = 44 HLA-A*03:01+ patients with a PIK3CA (E545K) cancer and an HLA-A LOH event, 23 of 44 (52.2%) lost HLA-A*03:01, whereas 21 of 44 (47.7%) lost an alternative HLA-A allele. This evidence concerns the gene HLA-A and cancer.